Literature DB >> 1577231

A case of combined primary biliary cirrhosis, ulcerative colitis and chronic myelocytic leukemia.

K Akahoshi1, Y Miyata, M Hashimoto, S Koga, Y Chijiiwa, T Misawa, E Suematsu, J Nishimura, H Nawata.   

Abstract

A rare case of primary biliary cirrhosis, ulcerative colitis and chronic myelocytic leukemia is described in a 49-year-old Japanese diabetic woman. Primary biliary cirrhosis was diagnosed by characteristic liver histology and positive serum mitochondrial antibody test. Ulcerative colitis was diagnosed by typical findings of barium enema and colonoscopy, negative fecal test for pathogens and compatible rectal histology. Chronic myelocytic leukemia was determined by representative hematologic findings and positive result for Ph1 chromosome. This is the first case with combination of primary biliary cirrhosis, ulcerative colitis and chronic myelocytic leukemia.

Entities:  

Mesh:

Year:  1992        PMID: 1577231     DOI: 10.1007/bf02777731

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  23 in total

Review 1.  Mechanisms of activation of human natural killer cells against tumor and virus-infected cells.

Authors:  D Santoli; H Koprowski
Journal:  Immunol Rev       Date:  1979       Impact factor: 12.988

2.  Precipitating antimitochondrial antibodies in Japanese patients with primary biliary cirrhosis.

Authors:  K Miyachi; S Watanabe; M Yamashiki; T Hiwatashi; F Ichida
Journal:  Am J Gastroenterol       Date:  1984-09       Impact factor: 10.864

3.  Impaired natural killer cell activity in patients with inflammatory bowel disease: evidence for a qualitative defect.

Authors:  C H Ginsburg; J T Dambrauskas; K A Ault; Z M Falchuk
Journal:  Gastroenterology       Date:  1983-10       Impact factor: 22.682

4.  Acute myelogenous leukemia in patients with ulcerative colitis.

Authors:  T L Fabry; D B Sachar; H D Janowitz
Journal:  J Clin Gastroenterol       Date:  1980-09       Impact factor: 3.062

5.  Primary biliary cirrhosis and chronic pancreatitis in a patient with ulcerative colitis.

Authors:  Y Kato; H Morimoto; M Unoura; K Kobayashi; N Hattori; Y Nakanuma
Journal:  J Clin Gastroenterol       Date:  1985-10       Impact factor: 3.062

6.  Inflammatory bowel disease and leukemia.

Authors:  E M Cohn; B Pearlstine
Journal:  J Clin Gastroenterol       Date:  1984-02       Impact factor: 3.062

7.  In vitro cell-mediated cytotoxicity in primary biliary cirrhosis and chronic hepatitis. Dysfunction of spontaneous cell-mediated cytotoxicity in primary biliary cirrhosis.

Authors:  J M Vierling; D L Nelson; W Strober; D M Bundy; E A Jones
Journal:  J Clin Invest       Date:  1977-11       Impact factor: 14.808

8.  Hepatobiliary complications of ulcerative colitis.

Authors:  M Lupinetti; D Mehigan; J L Cameron
Journal:  Am J Surg       Date:  1980-01       Impact factor: 2.565

9.  Inflammatory bowel disease and leukemia. A report of seven cases of leukemia in ulcerative colitis and Crohn's disease and review of the literature.

Authors:  S H Mir Madjlessi; R G Farmer; J K Weick
Journal:  Dig Dis Sci       Date:  1986-10       Impact factor: 3.199

10.  Serum autoantibodies, ulcerative colitis and primary sclerosing cholangitis.

Authors:  R W Chapman; M Cottone; W S Selby; H A Shepherd; S Sherlock; D P Jewell
Journal:  Gut       Date:  1986-01       Impact factor: 23.059

View more
  3 in total

Review 1.  Primary biliary cirrhosis and ulcerative colitis: a case report and review of literature.

Authors:  Wen-Bin Xiao; Yu-Lan Liu
Journal:  World J Gastroenterol       Date:  2003-04       Impact factor: 5.742

2.  Ulcerative colitis associated with primary biliary cirrhosis.

Authors:  M Koulentaki; I E Koutroubakis; E Petinaki; M Tzardi; H Oekonomaki; I Mouzas; E A Kouroumalis
Journal:  Dig Dis Sci       Date:  1999-10       Impact factor: 3.199

3.  Chronic myelogenous leukemia in ulcerative colitis.

Authors:  Konstantinos H Katsanos; Ioannis Vagias; Vasileios E Tsianos; Amalia Vassou; Epameinondas V Tsianos
Journal:  Ann Gastroenterol       Date:  2011
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.